Maria J Redondo1,2, Ashok Balasubramanyam3. 1. Section of Diabetes and Endocrinology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA. 2. Texas Children's Hospital, Houston, TX 77030, USA. 3. Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract
CONTEXT: Accumulating evidence indicates that type 2 diabetes (T2D) is phenotypically heterogeneous. Defining and classifying variant forms of T2D are priorities to better understand its pathophysiology and usher clinical practice into an era of "precision diabetes." EVIDENCE ACQUISITION AND METHODS: We reviewed literature related to heterogeneity of T2D over the past 5 decades and identified a range of phenotypic variants of T2D. Their descriptions expose inadequacies in current classification systems. We attempt to link phenotypically diverse forms to pathophysiology, explore investigative methods that have characterized "atypical" forms of T2D on an etiological basis, and review conceptual frameworks for an improved taxonomy. Finally, we propose future directions to achieve the goal of an etiological classification of T2D. EVIDENCE SYNTHESIS: Differences among ethnic and racial groups were early observations of phenotypic heterogeneity. Investigations that uncover complex interactions of pathophysiologic pathways leading to T2D are supported by epidemiological and clinical differences between the sexes and between adult and youth-onset T2D. Approaches to an etiological classification are illustrated by investigations of atypical forms of T2D, such as monogenic diabetes and syndromes of ketosis-prone diabetes. Conceptual frameworks that accommodate heterogeneity in T2D include an overlap between known diabetes types, a "palette" model integrated with a "threshold hypothesis," and a spectrum model of atypical diabetes. CONCLUSION: The heterogeneity of T2D demands an improved, etiological classification scheme. Excellent phenotypic descriptions of emerging syndromes in different populations, continued clinical and molecular investigations of atypical forms of diabetes, and useful conceptual models can be utilized to achieve this important goal.
CONTEXT: Accumulating evidence indicates that type 2 diabetes (T2D) is phenotypically heterogeneous. Defining and classifying variant forms of T2D are priorities to better understand its pathophysiology and usher clinical practice into an era of "precision diabetes." EVIDENCE ACQUISITION AND METHODS: We reviewed literature related to heterogeneity of T2D over the past 5 decades and identified a range of phenotypic variants of T2D. Their descriptions expose inadequacies in current classification systems. We attempt to link phenotypically diverse forms to pathophysiology, explore investigative methods that have characterized "atypical" forms of T2D on an etiological basis, and review conceptual frameworks for an improved taxonomy. Finally, we propose future directions to achieve the goal of an etiological classification of T2D. EVIDENCE SYNTHESIS: Differences among ethnic and racial groups were early observations of phenotypic heterogeneity. Investigations that uncover complex interactions of pathophysiologic pathways leading to T2D are supported by epidemiological and clinical differences between the sexes and between adult and youth-onset T2D. Approaches to an etiological classification are illustrated by investigations of atypical forms of T2D, such as monogenic diabetes and syndromes of ketosis-prone diabetes. Conceptual frameworks that accommodate heterogeneity in T2D include an overlap between known diabetes types, a "palette" model integrated with a "threshold hypothesis," and a spectrum model of atypical diabetes. CONCLUSION: The heterogeneity of T2D demands an improved, etiological classification scheme. Excellent phenotypic descriptions of emerging syndromes in different populations, continued clinical and molecular investigations of atypical forms of diabetes, and useful conceptual models can be utilized to achieve this important goal.
Authors: Michael P Bancks; Alain G Bertoni; Mercedes Carnethon; Haiying Chen; Mary Frances Cotch; Unjali P Gujral; David Herrington; Alka M Kanaya; Moyses Szklo; Dhananjay Vaidya; Namratha R Kandula Journal: J Clin Endocrinol Metab Date: 2021-04-23 Impact factor: 5.958
Authors: Babak Mokhlesi; Ashley H Tjaden; Karla A Temple; Sharon L Edelstein; Susan Sam; Kristen J Nadeau; Tamara S Hannon; Shalini Manchanda; Kieren J Mather; Steven E Kahn; David A Ehrmann; Eve Van Cauter Journal: Diabetes Care Date: 2021-02-05 Impact factor: 19.112
Authors: Maria J Redondo; Jesse Muniz; Luisa M Rodriguez; Dinakar Iyer; Fariba Vaziri-Sani; Morey W Haymond; Christiane S Hampe; Michael L Metzker; Struan F A Grant; Ashok Balasubramanyam Journal: BMJ Open Diabetes Res Care Date: 2014-04-06
Authors: Christine Therese Ferrara; Susan Michelle Geyer; Yuk-Fun Liu; Carmella Evans-Molina; Ingrid M Libman; Rachel Besser; Dorothy J Becker; Henry Rodriguez; Antoinette Moran; Stephen E Gitelman; Maria J Redondo Journal: Diabetes Care Date: 2017-02-15 Impact factor: 19.112
Authors: Wade C Haaland; Diane I Scaduto; Mario R Maldonado; Dena L Mansouri; Ramaswami Nalini; Dinakar Iyer; Sanjeet Patel; Anu Guthikonda; Christiane S Hampe; Ashok Balasubramanyam; Michael L Metzker Journal: Diabetes Care Date: 2009-02-19 Impact factor: 17.152
Authors: Scott J Pilla; Ashok Balasubramanyam; William C Knowler; Mariana Lazo; David M Nathan; Xavier Pi-Sunyer; Jeanne M Clark; Nisa M Maruthur Journal: Autoimmunity Date: 2019-01-02 Impact factor: 2.815
Authors: M N Weedon; A T Hattersley; K A Patel; R A Oram; S E Flanagan; E De Franco; K Colclough; M Shepherd; S Ellard Journal: Diabetes Date: 2016-04-05 Impact factor: 9.461
Authors: Barbara M Brooks-Worrell; Dinakar Iyer; Ivonne Coraza; Christiane S Hampe; Ramaswami Nalini; Kerem Ozer; Radhika Narla; Jerry P Palmer; Ashok Balasubramanyam Journal: Diabetes Care Date: 2013-10-15 Impact factor: 19.112
Authors: Maria J Redondo; Susan Geyer; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John Wentworth; Ping Xu; Alberto Pugliese Journal: Diabetes Care Date: 2017-10-12 Impact factor: 19.112